Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kashuba

Showing results (311-320 of 555) with videos related to

Pageof 56
Sort By:
Journal of Experimental & Clinical Cancer Research : CR|June 18, 2015
Confrontation of fibroblasts with cancer cells in vitro: gene network analysis of transcriptome changes and differential capacity to inhibit tumor growthAndrey Alexeyenko, Twana Alkasalias, Tatiana Pavlova, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 10, 2018
Differences in Local and Systemic TFV PK Among Premenopausal Versus Postmenopausal Women Exposed to TFV 1% Vaginal GelAndrea Ries Thurman, Neelima Chandra, Nazita Yousefieh, et al.
Genomics|December 1, 1991
New strategy for mapping the human genome based on a novel procedure for construction of jumping librariesE R Zabarovsky, F Boldog, R Erlandsson, et al.
Journal of Virology|June 5, 2009
Suppression of human immunodeficiency virus type 1 (HIV-1) viremia with reverse transcriptase and integrase inhibitors, CD4+ T-cell recovery, and viral rebound upon interruption of therapy in a new model for HIV treatment in the humanized Rag2-/-{gamma}c-/- mouseShailesh K Choudhary, Naser L Rezk, William L Ince, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 24, 2009
Maraviroc concentrates in the cervicovaginal fluid and vaginal tissue of HIV-negative womenJulie B Dumond, Kristine B Patterson, Allison L Pecha, et al.
Cancer Genetics and Cytogenetics|June 1, 1995
A group of NotI jumping and linking clones cover 2.5 Mb in the 3p21-p22 region suspected to contain a tumor suppressor geneV I Kashuba, A Szeles, R Allikmets, et al.
Clinical Pharmacokinetics|October 10, 2012
Pharmacokinetic modelling of efavirenz, atazanavir, lamivudine and tenofovir in the female genital tract of HIV-infected pre-menopausal womenJulie B Dumond, Melanie R Nicol, Racheal N Kendrick, et al.
Oncotarget|September 16, 2015
Integrin α9 gene promoter is hypermethylated and downregulated in nasopharyngeal carcinomaImran Nawaz, Li-Fu Hu, Zi-Ming Du, et al.
AIDS Patient Care and Stds|July 21, 2011
Effects of the H2-receptor antagonist famotidine on the pharmacokinetics of atazanavir-ritonavir with or without tenofovir in HIV-infected patientsXiaodong Wang, Marta Boffito, Jenny Zhang, et al.
Genomics|June 1, 1994
Shot-gun sequencing strategy for long-range genome mapping: a pilot studyE R Zabarovsky, V I Kashuba, B Pettersson, et al.
Pageof 56

Showing results (311-320 of 555) with videos related to

Sort By:
Pageof 56
Journal of Experimental & Clinical Cancer Research : CR|June 18, 2015
Confrontation of fibroblasts with cancer cells in vitro: gene network analysis of transcriptome changes and differential capacity to inhibit tumor growthAndrey Alexeyenko, Twana Alkasalias, Tatiana Pavlova, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 10, 2018
Differences in Local and Systemic TFV PK Among Premenopausal Versus Postmenopausal Women Exposed to TFV 1% Vaginal GelAndrea Ries Thurman, Neelima Chandra, Nazita Yousefieh, et al.
Genomics|December 1, 1991
New strategy for mapping the human genome based on a novel procedure for construction of jumping librariesE R Zabarovsky, F Boldog, R Erlandsson, et al.
Journal of Virology|June 5, 2009
Suppression of human immunodeficiency virus type 1 (HIV-1) viremia with reverse transcriptase and integrase inhibitors, CD4+ T-cell recovery, and viral rebound upon interruption of therapy in a new model for HIV treatment in the humanized Rag2-/-{gamma}c-/- mouseShailesh K Choudhary, Naser L Rezk, William L Ince, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 24, 2009
Maraviroc concentrates in the cervicovaginal fluid and vaginal tissue of HIV-negative womenJulie B Dumond, Kristine B Patterson, Allison L Pecha, et al.
Cancer Genetics and Cytogenetics|June 1, 1995
A group of NotI jumping and linking clones cover 2.5 Mb in the 3p21-p22 region suspected to contain a tumor suppressor geneV I Kashuba, A Szeles, R Allikmets, et al.
Clinical Pharmacokinetics|October 10, 2012
Pharmacokinetic modelling of efavirenz, atazanavir, lamivudine and tenofovir in the female genital tract of HIV-infected pre-menopausal womenJulie B Dumond, Melanie R Nicol, Racheal N Kendrick, et al.
Oncotarget|September 16, 2015
Integrin α9 gene promoter is hypermethylated and downregulated in nasopharyngeal carcinomaImran Nawaz, Li-Fu Hu, Zi-Ming Du, et al.
AIDS Patient Care and Stds|July 21, 2011
Effects of the H2-receptor antagonist famotidine on the pharmacokinetics of atazanavir-ritonavir with or without tenofovir in HIV-infected patientsXiaodong Wang, Marta Boffito, Jenny Zhang, et al.
Genomics|June 1, 1994
Shot-gun sequencing strategy for long-range genome mapping: a pilot studyE R Zabarovsky, V I Kashuba, B Pettersson, et al.
Pageof 56